DK1021404T3 - Azetidinonderivater til behandling af HCMV-infektioner - Google Patents

Azetidinonderivater til behandling af HCMV-infektioner

Info

Publication number
DK1021404T3
DK1021404T3 DK98947255T DK98947255T DK1021404T3 DK 1021404 T3 DK1021404 T3 DK 1021404T3 DK 98947255 T DK98947255 T DK 98947255T DK 98947255 T DK98947255 T DK 98947255T DK 1021404 T3 DK1021404 T3 DK 1021404T3
Authority
DK
Denmark
Prior art keywords
alkyl
het
aryl
phenyl
lower alkyl
Prior art date
Application number
DK98947255T
Other languages
Danish (da)
English (en)
Inventor
Eric Malenfant
Robert Deziel
William W Ogilvie
Jeffrey O'meara
Original Assignee
Boehringer Ingelheim Ca Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Ca Ltd filed Critical Boehringer Ingelheim Ca Ltd
Application granted granted Critical
Publication of DK1021404T3 publication Critical patent/DK1021404T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • A61P31/22Antivirals for DNA viruses for herpes viruses
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D205/00Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D205/00Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • C07D205/09Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams with a sulfur atom directly attached in position 4

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK98947255T 1997-10-07 1998-10-06 Azetidinonderivater til behandling af HCMV-infektioner DK1021404T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US6155097P 1997-10-07 1997-10-07
PCT/CA1998/000952 WO1999018071A1 (en) 1997-10-07 1998-10-06 Azetidinone derivatives for the treatment of hcmv infections

Publications (1)

Publication Number Publication Date
DK1021404T3 true DK1021404T3 (da) 2003-03-24

Family

ID=22036487

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98947255T DK1021404T3 (da) 1997-10-07 1998-10-06 Azetidinonderivater til behandling af HCMV-infektioner

Country Status (11)

Country Link
US (1) US6239125B1 (de)
EP (1) EP1021404B1 (de)
JP (1) JP2001519328A (de)
AT (1) ATE230725T1 (de)
AU (1) AU9425998A (de)
CA (1) CA2301548C (de)
DE (1) DE69810651T2 (de)
DK (1) DK1021404T3 (de)
ES (1) ES2187063T3 (de)
PT (1) PT1021404E (de)
WO (1) WO1999018071A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006020049A2 (en) 2004-07-15 2006-02-23 Amr Technology, Inc. Aryl-and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin
KR100599876B1 (ko) * 2004-08-31 2006-07-13 한국화학연구원 2-아릴메틸아제티딘 카바페넴 유도체 및 그의 제조방법
US9156812B2 (en) 2008-06-04 2015-10-13 Bristol-Myers Squibb Company Crystalline form of 6-[(4S)-2-methyl-4-(2-naphthyl)-1,2,3,4-tetrahydroisoquinolin-7-yl]pyridazin-3-amine
KR20120034644A (ko) * 2009-05-12 2012-04-12 알바니 몰레큘라 리써치, 인크. 아릴, 헤테로아릴, 및 헤테로사이클 치환된 테트라하이드로이소퀴놀린 및 이의 용도
CA2760837C (en) * 2009-05-12 2018-04-03 Albany Molecular Research, Inc. 7-([1,2,4]triazolo[1,5-.alpha.]pyridin-6-yl)-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydroisoquinoline and use thereof
EP2429293B1 (de) 2009-05-12 2014-10-29 Bristol-Myers Squibb Company KRISTALLINE FORMEN VON (S)-7-([1,2,4]TRIAZOL[1,5-a]PYRIDIN-6-YL)-4-(3,4-DICHLORPHENYL)-1,2,3,4-TETRAHYDROISOCHINOLIN UND IHRE VERWENDUNG
AU2019339777B2 (en) 2018-09-12 2022-09-01 Novartis Ag Antiviral pyridopyrazinedione compounds
JP7417715B2 (ja) 2019-09-26 2024-01-18 ノバルティス アーゲー 抗ウイルスピラゾロピリジノン化合物

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5229381A (en) * 1983-12-01 1993-07-20 Merck & Co., Inc. Substituted azetidinones as anti-inflammatory and antidegenerative agents
US4680391A (en) 1983-12-01 1987-07-14 Merck & Co., Inc. Substituted azetidinones as anti-inflammatory and antidegenerative agents
NZ228600A (en) * 1988-04-11 1992-02-25 Merck & Co Inc 1-(benzylaminocarbonyl)-4-phenoxy-azetidin-2-one derivatives
DE69032810T2 (de) 1989-01-03 1999-06-17 Marcos Y Kleinerman Fernmessung physikalischer Variablen mit faseroptischen Systemen
US5104862A (en) 1991-03-20 1992-04-14 Merck & Co., Inc. Bethalactam elastase inhibitors containing phosphorous acid derivatives at the 4-position of the 2-azetidinone
US5100880A (en) 1991-03-20 1992-03-31 Merck & Co., Inc. Novel betalactam elastase inhibitors containing phosphorous acid derivatives at the 4-position of the 2-azetidinone
GB2266527A (en) * 1992-03-17 1993-11-03 Merck & Co Inc Substituted azetidinones useful in the treatment of leukemia
GB9314350D0 (en) * 1993-07-12 1993-08-25 Zeneca Ltd Armide derivatives
CN1144488A (zh) * 1994-03-23 1997-03-05 东京田边制药株式会社 新型呼吸道病毒性疾病治疗药物
JP2001508395A (ja) * 1996-01-11 2001-06-26 スミスクライン・ビーチャム・コーポレイション 新規シクロアルキル置換イミダゾール
AU710876B2 (en) * 1996-02-21 1999-09-30 Darwin Discovery Limited Quinolones and their therapeutic use
JPH09255547A (ja) * 1996-03-22 1997-09-30 Kao Corp 皮膚外用剤

Also Published As

Publication number Publication date
PT1021404E (pt) 2003-04-30
ES2187063T3 (es) 2003-05-16
WO1999018071A1 (en) 1999-04-15
DE69810651T2 (de) 2003-08-21
EP1021404B1 (de) 2003-01-08
DE69810651D1 (de) 2003-02-13
CA2301548A1 (en) 1999-04-15
ATE230725T1 (de) 2003-01-15
AU9425998A (en) 1999-04-27
US6239125B1 (en) 2001-05-29
EP1021404A1 (de) 2000-07-26
JP2001519328A (ja) 2001-10-23
CA2301548C (en) 2005-05-17

Similar Documents

Publication Publication Date Title
HRP20010477B1 (en) 3-azabicyclo[3.1.0]hexane derivatives as opiate receptor ligands
DE69315079D1 (de) Beta-aminoalkyl und beta-n-peptidylaminoalkylborsäure
CA2140598A1 (en) Prolineamide derivatives
NO975901D0 (no) Vinyl-pyrrolidinon cefalosporiner med basiske substituenter
DK1021404T3 (da) Azetidinonderivater til behandling af HCMV-infektioner
HUP0203787A2 (hu) Hidroxi-acetil-piperazinnal szubsztituált oxazolidinon-benzoesav-észterek, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
ATE231124T1 (de) Azetidinonderivate zur behandlung von hcmv entzündungen
NO885549D0 (no) Fremgangsmaate for fremstilling av amid-derivater.
DE69132707D1 (de) N-Acyldipeptide, und pharmazeutische Präparate davon
ES2067635T3 (es) Derivados heterociclicos de beta-aminoacidos acilaminodiolicos.
DE69408888D1 (de) Neue reaktive Thiophosphat-Derivate von Thia(dia)zol-Essigsäure und Verfahren zur Herstellung derselben
ATE224872T1 (de) Azetidinonderivate zur behandlung von hcmv entzündungen
MX9708422A (es) Esteres de carbapenemas.
FI922268A0 (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten N-difenyylialkyylialkoksisubstituoitujen 3-piperidiinikarboksyylihappojohdannaisten valmistamiseksi
NZ331180A (en) Specific immunophilin ligands with indole structure as antiasthmatics and immunosuppressants
DE50000905D1 (de) Verfahren zur Herstellung von N-Acyl-aminosäureestern und N-Acyl-aminoacetalen
HUP0203921A2 (hu) Diazepin-karboxamid-származékok, eljárás a vegyületek előállítására, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk